HEART FAILURE NYHA CLASS II
Clinical trials for HEART FAILURE NYHA CLASS II explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE NYHA CLASS II trials appear
Sign up with your email to follow new studies for HEART FAILURE NYHA CLASS II, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart failure combo shows promise in small trial
Disease control CompletedThis study looked at whether adding sildenafil to the standard drug dapagliflozin helps heart failure patients who also have high blood pressure in their lungs. 100 people with mild heart failure took part. The goal was to see if the combination improved heart pumping strength an…
Matched conditions: HEART FAILURE NYHA CLASS II
Phase: NA • Sponsor: Fayoum University • Aim: Disease control
Last updated May 26, 2026 04:37 UTC
-
Smart heart monitor could improve care for heart failure patients
Disease control CompletedThis study tested a special heart monitor (Reveal LINQ) that tracks heart health and uses an algorithm to alert doctors when a patient's heart failure might be getting worse. 826 people with moderate heart failure (NYHA class II or III) took part. The goal was to see if using thi…
Matched conditions: HEART FAILURE NYHA CLASS II
Phase: NA • Sponsor: Medtronic Cardiac Rhythm and Heart Failure • Aim: Disease control
Last updated May 22, 2026 14:01 UTC
-
New MRI scan could spot hidden heart disease in seniors
Diagnosis CompletedThis study tested whether a special heart MRI scan (T1 mapping) can accurately diagnose cardiac amyloidosis, a condition where abnormal proteins build up in the heart. Researchers studied 112 older adults with heart failure and thickened heart walls. The goal was to see if this s…
Matched conditions: HEART FAILURE NYHA CLASS II
Sponsor: University of Leipzig • Aim: Diagnosis
Last updated May 26, 2026 04:38 UTC